EPRXEupraxia Pharmaceuticals Inc. Common Stock

6.730USDMkt Cap: 443.55M $P/E:

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug de…

Key Statistics

Company
Market Cap443.55M $
Enterprise Value339.65M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-38.58M $
Revenue/Share
Last Price6.730 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees49
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-6.46
PEG
EV/EBITDA-5.97
EV/Revenue
P/S
P/B4.33
EPS (TTM)-1.02
EPS (Forward)-1.04
52W Range
6.67930% of range6.850
52W High6.850 USD
52W Low6.679 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-47.02%
ROA-44.78%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-28.55M $
CapEx (TTM)588.95K $
FCF Margin
FCF Yield-4.27%
Net Debt-131.82M $
Net Debt/EBITDA2.32
Balance Sheet
Debt/Equity0.00
Current Ratio16.00
Quick Ratio15.71
Book Value/Sh1.554 USD
Cash/Share2.028 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)16.35 USD
Upside (mean)+142.9%
Target Range11.00 USD25.00 USD
$11.00+142.9% to mean$25.00
# Analysts10
Ownership
Shares Out.65.91M
Float55.67M
Insiders14.22%
Institutions45.02%
Short Interest
Short Ratio16.6d
Short % Out.9.25%
Shares Short5.92M
Short (prev mo.)5.46M
Technical
SMA 506.488 (+3.7%)
SMA 2007.077 (-4.9%)
Beta1.50
S&P 52W Chg19.18%
Avg Vol (30d)297.26K
Avg Vol (10d)246.89K
Technical Indicators
RSI (14)53.1
MACD0.1012
MACD Signal0.0744
MACD Hist.+0.0268
BB Upper7.098 USD
BB Middle6.577 USD
BB Lower6.055 USD
BB Width15.87%
ATR (14)0.3365 USD
Vol Ratio (20d)0.81x